Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1187
TNBC
Basal A
Etoposide
TOP2
TOP
7432.074
uM
0.30344
1.52030
-0.9717 -1.0000 0.6817 0.8363
0.9423
0.8598
HCC1187
TNBC
Basal A
Etoposide
TOP2
TOP
7431.074
uM
1.17190
3.15340
-0.8942 -0.8790 1.0249 0.6849
0.9885
1.4349
HCC1187
TNBC
Basal A
Fascaplysin
CDK4
CDK
7432.084
uM
0.01028
0.01685
-0.9998 -0.9951 2.2156 1.1594
0.9992
0.8538
HCC1187
TNBC
Basal A
Fascaplysin
CDK4
CDK
7433.084
uM
0.01972
0.03502
-0.9962 -0.9950 1.9076 1.0637
0.9998
1.0291
HCC1187
TNBC
Basal A
FR180204
ERK1/2
MAPK
10518.137
uM
25.61280
147.06970
0.4349 -1.0000 0.6286 0.1216
0.7415
1.2405
HCC1187
TNBC
Basal A
FR180204
ERK1/2
MAPK
10753.149
uM
57.42480
297.26360
0.6138 -1.0000 0.6682 0.0749
0.8238
1.4167
HCC1187
TNBC
Basal A
FTase Inhibitor I
Ftase
MAPK
10753.154
uM
inf
inf
1.0162 1.0162 0.0000 -0.0376
-5.9291
1.4444
HCC1187
TNBC
Basal A
FTase Inhibitor I
Ftase
MAPK
10518.142
uM
inf
inf
0.9343 0.9343 0.0000 0.0364
-0.0557
1.2869
HCC1187
TNBC
Basal A
Gefitinib
EGFR
ErbB
7812.016
uM
29.60580
38.26770
0.4096 -0.4031 2.3039 0.0530
0.9455
1.0628
HCC1187
TNBC
Basal A
Gefitinib
EGFR
ErbB
7811.044
uM
24.92130
30.93870
-0.1669 -0.9744 5.0000 0.0514
0.9684
0.3073
HCC1187
TNBC
Basal A
Geldanamycin
HSP90
HSP90
9244.012
uM
0.01697
0.02114
-0.3844 -0.5319 3.3017 1.0194
0.940
0.4292
HCC1187
TNBC
Basal A
Geldanamycin
HSP90
HSP90
7812.04
uM
0.01525
0.01354
0.2627 0.2243 5.0000 0.5217
0.9633
1.0573
HCC1187
TNBC
Basal A
Geldanamycin
HSP90
HSP90
7811.04
uM
0.05228
0.06299
-0.8492 -0.7691 5.0000 0.9963
0.9944
0.3921
HCC1187
TNBC
Basal A
Gemcitabine
DNA replication
DNA replication
7812.011
uM
518.62050
0.52096
0.4679 0.4620 0.3733 0.2402
0.7728
1.0620
HCC1187
TNBC
Basal A
Gemcitabine
DNA replication
DNA replication
7811.011
uM
0.30922
0.45060
-0.2941 -0.2908 1.2176 0.6183
0.9383
0.4400
HCC1187
TNBC
Basal A
Glycyl-H-1152
ROCK2
10753.15
uM
0.72667
1.03870
-0.4079 -0.3348 1.4348 0.3876
0.9719
1.4129
HCC1187
TNBC
Basal A
Glycyl-H-1152
ROCK2
10518.138
uM
0.43471
0.58591
-0.2990 -0.2511 1.3632 0.3973
0.9939
1.3413
HCC1187
TNBC
Basal A
GSK1070916
AURK
AURK
7812.001
uM
0.01221
0.0150
-0.8531 -0.6455 4.0237 0.9376
0.9857
1.0060
HCC1187
TNBC
Basal A
GSK1070916
AURK
AURK
7811.001
uM
0.01148
0.01402
-0.9576 -0.8571 5.0000 1.0993
0.9874
0.4464
HCC1187
TNBC
Basal A
GSK1070916
AURK
AURK
9244.001
uM
0.00874
0.01067
-0.8996 -0.8591 5.0000 1.1518
0.9961
0.5421
HCC1187
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7432.098
uM
2.47890
2.71390
-0.9806 -0.2864 5.0000 0.4040
0.6929
1.0423
HCC1187
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7433.071
uM
103.91080
175.90610
0.4637 -0.1278 0.4324 0.1139
0.9308
1.0393
HCC1187
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7431.092
uM
2.7610
4.60660
-0.9070 -0.9485 2.0780 0.4809
0.9690
1.5006
HCC1187
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7433.098
uM
3.16530
5.66550
-0.9600 -0.9903 1.8761 0.4415
0.9811
1.1392
HCC1187
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7433.09
uM
1.91130
1.3970
0.4067 0.3957 4.9989 0.1848
0.9858
0.8477